Author

Stefan Gajewski

Observed names: Gajewski Stefan, S. Gajewski

Institution: Nurix (United States)

Observed institution: Nurix (United States)

ORCID: 0000-0001-5432-0403

Observed ORCID: 0000-0001-5432-0403

OpenAlex ID: A5005589996

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

2024 · Skye Montoya, Jessie Bourcier, et al. · Science · 169

Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton’s Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies

2024 · Daniel W. Robbins, Mark A. Noviski, et al. · Journal of Medicinal Chemistry · 115

NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts

2022 · Deyi Zhang, Hailey M. Harris, et al. · Blood · 32

Molecular and Structural Basis of Pan-Resistance to BTK Degraders and Inhibitors

2026 · Quinlan Sievers, Hao Lu, et al. · Cancer Discovery · 3

Molecular and structural basis of pan-resistance to BTK targeting therapies via BTK A428D mutation

2025 · Quinlan Sievers, Hao Lu, et al. · Blood · 2

Bexobrutideg: A Selective, Catalytic Degrader of Bruton’s Tyrosine Kinase Overcomes Inhibitor Resistance and Suppresses Autoantibody-Mediated Disease

2026 · Mark Noviski, Paul Auger, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

Discovery and characterization of small molecule inhibitors of CBL-B that act as intramolecular glue to enhance T-cell anti-tumor activity

2026 · Gajewski Stefan, Taherbhoy M. Asad, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

Abstract 1651: NRX-0305: a pan-mutant BRAF degrader with broad preclinical efficacy, brain penetrance, and synergistic potential with MEKi across class 1/2/3 BRAF-mutant cancers

2025 · Alexandra Borodovsky, Ya-Wen Lu, et al. · Cancer Research · 1

Abstract 6733: Discovery and characterization of CBL-B intramolecular glue inhibitors that increase T cell activation and suppress tumor growth.

2026 · Stefan Gajewski, Asad Taherbhoy, et al. · Cancer Research

Crystal structure of wild-type Bruton's Tyrosine Kinase (BTK) in the apo form

2025 · S. Gajewski · Worldwide Protein Data Bank

Works count: 12

Citation count: 324

H-index: 3

I10-index: 3